Poly MedicureNSE:POLYMED -0.04%90 Operating Margin % is 13.50% as of Mar. 2026, which is 28% below its 10-year median of 18.69. GuruFocus rates NSE:POLYMED with a GF Score™ of 90/100 and a GF Value™ of ₹2,289.81 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Poly Medicure ranks better than 64.38% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Poly Medicure's Operating Income for the
three
months ended in Mar. 2026 was ₹722 Mil. Poly Medicure's Revenue for the
three
months ended in Mar. 2026 was ₹5,345 Mil. Therefore, Poly Medicure's Operating Margin % for the quarter that ended in Mar. 2026 was 13.50%.
Warning Sign:
Poly Medicure Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -1.1%.
The historical rank and industry rank for Poly Medicure's Operating Margin % or its related term are showing as below:
NSE:POLYMED'
s Operating Margin % Range Over the Past 10 Years
Min: 9.09 Med: 18.69 Max: 22.17
Current: 9.09
NSE:POLYMED's Operating Margin % is ranked better than 64.38% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 3.41
vs NSE:POLYMED: 9.09
Poly Medicure's 5-Year Average Operating Margin % Growth Rate was -1.10% per year.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Poly Medicure Operating Margin % Related Terms
Poly Medicure Operating Margin % Historical Data
* Premium members only.
The historical data trend for Poly Medicure's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:POLYMED vs ISRG, BDX, MDLN: Operating Margin % Comparison
For the Medical Instruments & Supplies subindustry, Poly Medicure's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Poly Medicure Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Poly Medicure's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Poly Medicure's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Poly Medicure's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Poly Medicure (NSE:POLYMED) has a Operating Margin % of 13.50% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Poly Medicure and its competitors. This is 28% below median its historical median of 18.69. Over the past decade, Poly Medicure's Operating Margin % has ranged from 9.09 to 22.17. According to the industry distribution chart, Poly Medicure ranks #291 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 35.6%.
Is Poly Medicure's Operating Margin % too high?
Poly Medicure's current Operating Margin % of 13.50% is 28% below median its 10-year median of 18.69. Over the past 10 years, this metric has ranged from a low of 9.09 to a high of 22.17. The Medical Devices & Instruments industry median Operating Margin % is 3.41. Poly Medicure's value of 13.50% is 295.9% above this industry median. Based on the distribution chart, Poly Medicure ranks #291 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Poly Medicure has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Poly Medicure's Operating Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Poly Medicure ranks #291 out of 817 companies for Operating Margin %. This puts Poly Medicure in the upper half of its industry. The industry median Operating Margin % is 3.41. Poly Medicure's value of 13.50% is 295.9% above this benchmark. Historically, Poly Medicure's own Operating Margin % has ranged from 9.09 to 22.17 over the past decade. While the company's 10-year median is 18.69 vs. the industry median of 3.41, Poly Medicure has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.41, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Poly Medicure's current Operating Margin % of 13.50% is 295.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Poly Medicure and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Poly Medicure's current Operating Margin % is 13.50%, which is 28% below median its own 10-year median of 18.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poly Medicure stock overvalued right now?
Based on GuruFocus' analysis, Poly Medicure (NSE:POLYMED) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹2,289.81, compared to a current price of ₹1,650.20 — trading 27.9% below its estimated fair value. The current Operating Margin % is 13.50%, which is 28% below median its 10-year median of 18.69 and 295.9% above the Medical Devices & Instruments industry median of 3.41. Poly Medicure's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Poly Medicure (NSE:POLYMED), the current Operating Margin % is 13.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Poly Medicure (NSE:POLYMED) Overvalued in 2026?
Based on GuruFocus' analysis, Poly Medicure stock appears to be undervalued.
The current stock price of ₹1,650.20 is trading 27.9% below its estimated GF Value™ of ₹2,289.81.
GuruFocus considers Poly Medicure to be Modestly Undervalued.
Key valuation signals for NSE:POLYMED:
Operating Margin %: 13.50% (28% below median its 10-year median of 18.69)
GF Value™: ₹2,289.81 vs. price of ₹1,650.20 (27.9% below fair value)
Industry Position: 295.9% above the Medical Devices & Instruments median (#291 of 817)
No single metric tells the full story. See the NSE:POLYMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.
90GF Score
Get the complete analysis for NSE:POLYMED
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:POLYMED has been successfully added to your 
